Aryl and biaryl compounds having MCH modulatory activity

Details Aryl and biaryl compounds having MCH modulatory activity Aryl and biaryl compounds having MCH modulatory activity

2006-04-25

2006-04-25

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C558S393000, C564S050000

Reexamination Certificate

active

07034056

ABSTRACT:
In one embodiment, this invention provides a novel class of compounds as antagonists of the MCH receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more of the compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration or one or more of diseases associated with the MCH receptor. An illustrative inventive compound is shown below:

REFERENCES:
patent: 3455940 (1969-07-01), Stecker
patent: 6043246 (2000-03-01), Fukami et al.
patent: 0068669 (1983-05-01), None
patent: 428434 (1991-05-01), None
patent: 0432 442 (1991-06-01), None
patent: 474561 (1992-03-01), None
patent: 515240 (1992-11-01), None
patent: 559538 (1993-09-01), None
patent: 0955 293 (1999-10-01), None
patent: 2717802 (1995-09-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 00/27845 (2000-03-01), None
patent: WO 00/25786 (2000-05-01), None
Clinical Science (2001), 100(2), 221-229.
Psychopharmacology (2003) 167: 103-111.
Proceedings of the National Academy of Sciences of the United States of America (2003), 100(17), 10085-10090.
Shimada, et al.,Nature, vol. 396(Dec. 17, 1998), pp. 670-673.
Edstrom, E.D. & Livinghouse, T.,J.Am. Chem. Soc. (1986), 1334-6.
Kano, et al.,Chem. Pharm. Bull., 1985, 33, 340-6.
Suzuki, A.,J. Amer. Chem. Soc., 111 (1989) 314.
Zhang, A.J., et,Tet. Lett. (1998), 39, 7439-7442.
Igarashi, Yakagaku Zassi, “Synthesis and pharmacology of basic . . . ”, (1973) vol. 93, No. 5,pp. 554-565.
Schultz, Helvetica Chimica Acta, “Total synthesis of (+)-8S, 13R)—cyclocelabenzine” (1996) vol. 79, No. 5, pp. 1295-1304.
Cherkashin, Dokl. Chem. (1990) vol. 313, No. 1, 3, pp 206-209.
Julia, Bull. Soc. Chim. Fr., (1966), pp. 1335-1342.
Ornstein, J. Med. Chem., “Biarylpropylsulfonamides as Novel, Potent . . . ”, (2000) No. 43, p. 4356, Example 5G, Table 1.
O'Brien, J. Med. Chem, “Inhibitors of acyl-CoA:cholesterol O-acyl . . . ” (1994), vol. 37, No. 12, pp. 1810-1822.
Leb, Life Sciences, “Melanin Concentrating Hormone Analogues” (1989) vol. 44, No. 7, pp. 451-457.
DeGraw, BNSDOCID, “Histamine Releasers” (1967) vol. 10, pp. 174-177.
BNSDOCID, XP 2208310A.

Affiliated with

Also associated with

Rating

Aryl and biaryl compounds having MCH modulatory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl and biaryl compounds having MCH modulatory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl and biaryl compounds having MCH modulatory activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3618975